TRPV1 and fatty liver disease: We hypothesized that chronic consumption of eugenol protected against hypercholesterolemia and fatty liver disease by causing an initial activation as an agonist, followed by long‐term desensitization of TRPV1, suggesting that the pharmacological effect of eugenol may be mediated by inhibition of TRPV131.